Literature DB >> 16986923

Przewalskin A: A new C23 terpenoid with a 6/6/7 carbon ring skeleton from Salvia przewalskii maxim.

Gang Xu1, Ai-Jun Hou, Rui-Rui Wang, Guang-Yu Liang, Yong-Tang Zheng, Ze-Yuan Liu, Xiao-Li Li, Yu Zhao, Sheng-Xiong Huang, Li-Yan Peng, Qin-Shi Zhao.   

Abstract

Przewalskin A (1), a novel C23 terpenoid with a 6/6/7 carbon ring skeleton, was isolated from Salvia przewalskii. Its structure was determined by comprehensive 1D NMR, 2D NMR, and MS spectroscopic analysis and subsequently confirmed by a single-crystal X-ray diffraction study of its PDC oxidation derivative (2). Compounds 1 and 2 showed modest anti-HIV-1 activity with EC50 = 41 and 89 microg/mL, respectively.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16986923     DOI: 10.1021/ol061609t

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

1.  Regioisomers Salviprolin A and B, Unprecedented Rosmarinic Acid Conjugated Dinorditerpenoids from Salvia przewalskii Maxim.

Authors:  Xiangdong Su; Yichuang Wu; Meifang Wu; Jielang Lu; Shujie Jia; Xin He; Shuna Liu; Yuyang Zhou; Hui Xing; Yongbo Xue
Journal:  Molecules       Date:  2021-11-18       Impact factor: 4.411

Review 2.  Uncommon Terpenoids from Salvia Species: Chemistry, Biosynthesis and Biological Activities.

Authors:  Salar Hafez Ghoran; Fatemeh Taktaz; Ali Akbar Mozafari; Murat Tunçtürk; Nazim Sekeroglu; Anake Kijjoa
Journal:  Molecules       Date:  2022-02-08       Impact factor: 4.411

3.  Molecular Mechanism of Salvia miltiorrhiza Bunge in Treating Cerebral Infarction.

Authors:  Xietao Ye; Jiali Liu; Xinyao Yuan; Songhong Yang; Yi Huang; Yan Chen
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-29       Impact factor: 2.629

4.  Synthesis and Cytotoxicities of Royleanone Derivatives.

Authors:  Cheng-Ji Li; Fan Xia; Rong Wu; Hong-Sheng Tan; Hong-Xi Xu; Gang Xu; Hong-Bo Qin
Journal:  Nat Prod Bioprospect       Date:  2018-06-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.